1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

ABCL - 1004

Long-Term Outcomes of Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review of Efficacy, Survival, Minimal Residual Disease, and Safety

$Preview of Long-Term Outcomes of Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review of Efficacy, Survival, Minimal Residual Disease, and Safety$

View Poster Contact Presenter

Poster Presenter

Sai Harsha Yendluri

Authors

Sai Harsha Yendluri

Part of Topic

Aggressive B-Cell Lymphoma (ABCL)

Long-term outcomes of Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.